SCHEMBL7430770

SCHEMBL7430770

CC(C)(C)OC(=O)C(C(=O)OC(C)(C)C)c1cc(F)c([N+](=O)[O-])c(OCc2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.42
ITGA4 P13612 1/20 0.42
ITGB7 P26010 1/20 0.42
CTSV O60911 2/20 0.40
CTSL P07711 2/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 2/20 0.38
HTT P42858 2/20 0.38
LTA4H P09960 1/20 0.37
MGMT P16455 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
COMT P21964 1/20 0.37
SYK P43405 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2434981 0.95 ITGA4 (0.39) CYP19A1ITGA4ITGB7CTSVCTSL
SCHEMBL7534714 0.88 CYP19A1 (0.40) CYP19A1ITGA4ITGB7CTSVCTSL
SCHEMBL2431866 0.81 PKM (0.36) MEN1MAPTKMT2AALDH1A1HTT
SCHEMBL646425 0.78 MYC (0.44) CYP19A1ITGA4ITGB7CTSVCTSL
SCHEMBL31667350 0.75 CYP19A1 (0.52) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL2434879 0.75 CYP19A1 (0.51) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL31321850 0.74 LMNA (0.53) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL2432543 0.74 CYP19A1 (0.44) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL29373054 0.73 KDM1A (0.52) CYP19A1CTSVCTSLMEN1MAPT
SCHEMBL22412563 0.73 KDM1A (0.52) CYP19A1CTSVCTSLMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 WO disclosed